Robert Lenk
Fortune : 32 435 $ au 31/05/2026
Fortune : 32 435 $ au 31/05/2026
Robert P.
Lenk was the founder of The Liposome Co., Inc., founded in 1981, and Argus Pharmaceuticals, Inc., founded in 1989, where the title held was Vice President-Research & Development.
Current jobs include Director at POP Biotechnologies, Inc., Partner at Houston Partners Private Equity Group LLC, and President at Lenk Pharmaceuticals, LLC since 2016.
Former jobs include President & Chief Executive Officer at Therapeutics 2000, Inc. from 1995 to 2003, Independent Non-Executive Director at Plus Therapeutics, Inc. from 2020 to 2026, President-Luna Nanoworks Division at Luna Innovations, Inc. from 2004 to 2010, President at OncoVector, Inc., and Chief Scientific Officer at MediVector, Inc. from 2010 to 2016.
Education includes undergraduate and doctorate degrees from the Massachusetts Institute of Technology.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
PLUS THERAPEUTICS, INC. 0,08 % | 18/03/2026 | 5 573 ( 0,08 % ) | 32 435 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
Houston Partners
Houston Partners Investment ManagersFinance Acts as an alternative investment manager | Corporate Officer/Principal | - |
Lenk Pharmaceuticals, LLC | President | 01/01/2016 |
POP Biotechnologies, Inc.
POP Biotechnologies, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Directeur/Membre du Conseil | - |
| Sociétés | Poste | Fin |
|---|---|---|
| PLUS THERAPEUTICS, INC. | Directeur/Membre du Conseil | 20/03/2026 |
MediVector, Inc.
MediVector, Inc. Medical/Nursing ServicesHealth Services MediVector, Inc. is a private company based in Cambridge, MA and has subsidiaries in the United States. | Directeur Technique/Scientifique/R&D | 01/01/2016 |
| LUNA INNOVATIONS INCORPORATED | Corporate Officer/Principal | 15/04/2010 |
Therapeutics 2000, Inc. | Directeur Général | 01/09/2003 |
Argus Pharmaceuticals, Inc.
Argus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Pharmaceutical concern | Fondateur | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 11 |
|---|---|
The Liposome Co., Inc.
The Liposome Co., Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures, and markets therapeutic products to treat cancer and related diseases | Health Technology |
Luna Innovations, Inc.
Luna Innovations, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops and distributes fiber optic test, measurement and control products | Electronic Technology |
Argus Pharmaceuticals, Inc.
Argus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Pharmaceutical concern | Health Technology |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Houston Partners
Houston Partners Investment ManagersFinance Acts as an alternative investment manager | Finance |
Plus Therapeutics, Inc.
Plus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops radio therapeutics products | Health Technology |
MediVector, Inc.
MediVector, Inc. Medical/Nursing ServicesHealth Services MediVector, Inc. is a private company based in Cambridge, MA and has subsidiaries in the United States. | Health Services |
OncoVector, Inc. | |
Therapeutics 2000, Inc. | |
Lenk Pharmaceuticals, LLC | |
POP Biotechnologies, Inc.
POP Biotechnologies, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national